Fetal pancreas size and maternal serum biomarkers glycated albumin and insulin-regulated aminopeptidase provide no potential for early prediction of gestational diabetes mellitus
- 27 November 2022
- journal article
- research article
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 308 (5) , 1505-1514
Abstract
Purpose We aimed to determine the predictive values of fetal pancreas size and maternal serum biomarkers glycated albumin (GA) and insulin-regulated aminopeptidase (IRAP) for gestational diabetes mellitus (GDM). Materials and methods In this prospective observational study including 109 pregnant women, the fetal pancreas size and maternal serum biomarkers GA and IRAP were measured at the gestational age of 20–22 weeks and later at the gestational age of 24–28 weeks, in 19 participants of them, GDM was confirmed with the 75-g oral glucose tolerance test (OGTT) and the fetal pancreas size was measured in all the participants again. Results The median fetal pancreas sizes were significantly higher in women with or without GDM when measured at the 24–28 weeks of pregnancy compared to those at the 20–22 weeks of pregnancy (p < 0.05). At both of the 20–22 and 24–28 weeks of pregnancy, the median values of fetal pancreas sizes in the women with or without GDM were found comparable (p > 0.05). There were no significant differences between pregnant women with or without GDM regarding maternal serum biomarkers GA and IRAP (p > 0.05). Multivariate logistic regression analysis revealed no meaningful association of study parameters with the development of GDM. Conclusion The fetal pancreas size and maternal serum biomarkers GA and IRAP provide no potential for early prediction of GDM at the 20–22 weeks of gestation. Further studies, including serial measurement of these parameters during the second and third trimesters of GDM pregnancies, may clarify their role in the antenatal care of women with GDM. Clinical trials NCT05392231.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Plasma fatty acid-binding protein 4 (FABP4) as a novel biomarker to predict gestational diabetes mellitusActa Diabetologica, 2016
- Factors affecting A1C in non-diabetic individuals: Review and meta-analysisClinica Chimica Acta, 2015
- First-Trimester Screening for Gestational Diabetes Mellitus Based on Maternal Characteristics and HistoryFetal Diagnosis and Therapy, 2014
- The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitusAmerican Journal of Obstetrics and Gynecology, 2010
- Role of the Insulin-Regulated Aminopeptidase IRAP in Insulin Action and DiabetesBiological and Pharmaceutical Bulletin, 2004
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.1998
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Sonographic detection of the fetal pancreasJournal of Clinical Ultrasound, 1989
- Ultrasonographic identification and measurement of the human fetal pancreas in uteroInternational Journal of Gynecology & Obstetrics, 1988
- Normal fetal anatomy.1982